RAYMOND D. BEAMS

Frisco, TX *****

Cell 214-***-****

ad4rd9@r.postjobfree.com

MEDICAL DEVICE SALES PROFESSIONAL

Accomplished professional with documented sales achievement in the Medical Device Industry seeking a company which will offer solid products along with a long term career opportunity. Demonstrated track record of mastering technology and associated healthcare arena. Successful startup and market development experience with four companies has developed skill sets for introducing new products/procedures to market, driving adoption and increasing physician referrals. This blueprint allows Medical Device Manufacturers as well as Hospitals and Physicians to drive growth through adoption, referral development and Strategic Market Development.

CORE COMPETENCIES

Cardiac Surgery / Thoracic Surgery

Heart Failure / ECMO

Cath Lab / Structural Heart Devices

Valve Repair and Replacement

Start-Ups / New Market Development

Referral Program Development

Endocardial / Epicardial Ablation

Strategic Account Management

Atrial Fibrillation / MAZE Procedure

Reimbursement Specialist and Trainer

Market and Business Development

Electrophysiology / Cardiology Sales

IDN’s/Key Accounts/C Suite Sales

Value Analysis Committee’s

Disruptive Technology Sales

CVICU / CCU / ICU Sales

Field Sales Trainer / Training Manager

CT, MRI, TEE, TTE and Fluoro

GENESIS MEDICAL GROUP Mar 2023 to present

1099 Consultant, Dallas, TX

Sales of cardiovascular devices used in the cardiac OR and cath lab. Specialties are Cardiac Surgeons, Structural Heart Cardiologists and Electrophysiologists. Also provide case support for these products. MediStim, Circa and Enable Medical.

ANCORA HEART, INC (Position eliminated due to company financial issues) Feb 2022 - Feb 2023

Manager, Therapy Development, Dallas, Texas

Responsible for the AccuCinch Ventricular Restoration System which is used to treat dilated cardiomyopathy (HFrEF), ischemic and nonischemic, in NYHA Class II, III and IV heart failure patients and coordinating its use in the CorCinch HF pivotal trial in 4 states (Texas, Oklahoma, Arkansas and Louisiana). I interfaced with Structural Heart Cardiology, Heart Failure Cardiology, Cardiac Surgery and their team of Research Coordinators. This trial is to gain FDA approval for the AccuCinch device by December 2024. The goal is to develop this procedure and market for commercialization pending FDA approval in late 2024. 8 sites have enrolled as implanting sites with 6 more pending. Responsibility for case support during the device implantation as well as physician and staff training before and during implant cases. Worked with physicians in case planning by reviewing, CT, MRI, TEE, TTE and Fluoroscopy. Interpreting TEE, TTE and Fluoroscopy during case support.

During the first 6 months I added Oklahoma Heart Institute/Hillcrest (Tulsa), Baptist Little Rock, Our Lady of the Lake (Baton Rouge)

By year end 2022 or early Q1 2023 Memorial Hermann (Houston), Methodist (Houston) and Texas Tech (Lubbock) will be added as implanting sites

ABBOTT LABORATORIES, INC Nov 2020 - Mar 2022

LVAD Account Executive, Dallas, TX

Sales and clinical support in Texas, Oklahoma, Louisiana, Arkansas, Kansas and Missouri of Heartmate 3 and LVAD monitoring services which are the Abbott platforms for remote patient monitoring called VADWatch. VADWATCH remote patient monitoring is a new sector of the LVAD market which I developed in my geography and drove adoption during Covid and beyond. It has since then become a standard of care recognized by ERAS. Also responsible for sales of replacement VAD equipment, wearables and patient supply contracts with associated LVAD/Transplant programs. Work closely with VAD/heart transplant surgeons and associated staff and CVICU / ICU

In Q1 2021, I moved my territory from last place #6 to #2 with an over Q1 finish of 115% to plan.

Q1 2021 closed Scott & White, Austin Heart. Q2 closed Baptist and St. Vincents, Little Rock, Integris Baptist, OKC.

Q2 2021 112% to plan. Q3 2021 101% to plan. Q4 2021 106% to plan. Q1 2022 99% to plan.

CLEARFLOW, INC (Furloughed April 2020 Due to Covid) Dec 2018 - May 2020

Clinical Sales Manager, Dallas, TX

Sales and clinical support of PleuraFlow Active Chest Clearance System to Cardiovascular surgeons and ICU staff in the Texas, Oklahoma, Arkansas, Kansas, Missouri, Colorado, Utah and New Mexico markets. Implant case support is with the Heart Failure / VAD / Cardiovascular and Thoracic Surgeon audience and support staff in the OR. Clinical support is training CVICU, CCU and ICU staff to manage patients on the PleuraFlow system.

In the first month I developed new customers and closed sales at the following: UT Southwestern, Dallas VA, Methodist Houston and St. Francis Tulsa. Oklahoma Heart Hospital, Integris Baptist OKC, Memorial Hermann Houston are in final stages of closing. 150% to plan for first full month in territory (January 2019).

First six months of 2019 closed Methodist Houston, Methodist San Jacinto, Bayshore and Clear Lake Medical Centers. Closed Methodist San Antonio in October 2019. 100% to plan with aggressive quota growth.

Lead sales force in 2019 with most new accounts closed at 9 accounts. Current leader as of 3/20 with 3 new accounts.

Provide education for all staff through live cases, conferences, classroom teaching and bedside instruction.

CARDIAC INSIGHT, INC. (6 month contract position) June 2018 – November 2018

Regional Director, Dallas, TX

Introduction and market development of the Cardea Solo wearable 7 day event monitor for arrhythmia detection to Interventional and general Cardiologists, Electrophysiologists and Cardiac Surgeons in the north Texas/Oklahoma market. Duties include sales of devices as well as capital portion which is the software and hardware for report generation and interpretation. Provide regular in-services for staff on application of the device on the patient, report generation and interpretation of the data for each patient report.

New accounts established are Baylor Heart Arrhythmia Center(DeVille), Cardiac Center of Texas(Khan), Waco Heart and Vascular(Myatt), Amarillo Heart Group(Desai), Cardiology Center of Amarillo(Cox), Longview Regional(Massare)

LIVANOVA (CARDIAC ASSIST, INC.) (Company sold, position eliminated 6/2018) Feb 2016 – june 2018

Therapy Development Specialist, Dallas, TX

Sales and clinical support of the Tandem Heart product line which consists of percutaneous left and right ventricular assist implantable devices for heart failure. Launched a new oxygenator as well as a capital ECMO platform to create a new market for Cardiac Assist, Inc. Implant case support is with the Cardiovascular Surgeon, Transplant and LVAD surgeon and Interventional Cardiologist audience in the OR and Cath Lab. Also work closely with Heart Failure Cardiologists to develop patient referral stream. Clinical support is training CVICU, CCU and ICU staff to manage patients on the Tandem Heart system. Covered Texas, Louisiana, Oklahoma and Arkansas.

Finished FY 2016 at 102% to plan ($2,325,000 actual sales vs $2,275,000 budget)

2016 Presidents Club

Only territory to achieve 1st half quota, 2nd half quota and FY 2016 quota.

Established 5 new accounts in FY 2016. These are Methodist Houston, Baylor University Medical Center, University Medical Center – Lubbock, Baptist Healthcare System, Little Rock and Hillcrest, Tulsa

2017 accounts opened: Baylor Heart Hospital, Dallas Methodist, Mercy (Rogers,AR), Medical Center Hospital (Odessa)

Finished 1st half 2017 at 98% to plan, sales of 1.2 million. Finished 2017 at 96%, sales of $2,376,930.

101% to plan at November 2018 when Cardiac Assist, Inc was bought by LivaNova. Sales force was let go.

Provided education for all staff through live cases, conferences, classroom teaching and bedside instruction.

NANOSONICS, INC Oct 2012 – Jan 2016

Regional Sales Manager, Dallas, TX

Manage the strategic sales cycle planning, implementation process and introduction to market the Trophon EPR high level disinfection system with over 40 GE Healthcare ultrasound representatives. The geographical was 14 states based out of Texas. Established 26 new accounts (Oct-Dec 2012) leading to the sale of over 60 Trophon systems.

2013 Trophon sales were 121 units; 50 + new accounts.

2014 Trophon sales were 280 units; 75 + new accounts.

2015 YTD sales ranking is #2 out 15 territories.

SORIN GROUP USA Aug 2007 - Sept 2012

Account Executive, U.S. Heart Valve Business, Dallas, TX

Represented the full line of valve replacement and repair products and a aortic valve conduit (Gelweave) for aortic dissections to Cardiovascular Surgeons in North Texas and Oklahoma, western Arkansas

Established 15 new implanting accounts for the Mitroflow tissue valve in 2008.

Increased 2009 territory sales over 2008 sales by $376,214 (65.3% growth). 2007, 2008, 2009 exceeded quota.

Developed a “Surgical Center of Excellence” at Baylor Heart Hospital in March 2010 to train CV Surgeons. This was a collaborative with hospital CEO, VP of Marketing and Baylor Research and Baylor KOL surgeons.

Promoted to Field Sales Trainer in 2008

Executive Sales Council 2009, 2010 and 2011

Marketing Advisory Panel 2010 and 2011

ATRICURE, INC. (Maze Surgical procedure was suspended by the FDA. Joined Sorin Group) June 2004 - Aug 2007

Regional Sales Manager, Dallas, TX

Launched the Atricure Isolator System to Cardiovascular and Thoracic Surgeons, Transplant Surgeons in northern/western Texas, Oklahoma, Arkansas, Missouri and Kansas creating a new surgical afib market in this geography. This bipolar radiofrequency energy ablation and mapping system is used to perform the MAZE procedure and treat Atrial Fibrillation. Key call points are the CV Surgeons, Transplant Surgeons, Electrophysiologists, Interventional Cardiologists and CVOR / Cath Lab directors.

FY 2004 territory quota was $582,000. During my first 7 months (June-Dec) I generated $408,397 in sales.

Finished 2004 131% to plan.

Established 4 new accounts in first 7 months.

FY 2005 exceeded a 57% quota increase. Finished at 111% to plan or $1,130,412 in sales.

Promoted to one of two “National Training Managers” to train new hires and continually develop tenured reps.

Opened 7 new “Concomitant” MAZE accounts and 3 new “Minimally Invasive” MAZE accounts in 05.

Developed a strategic account into the #1 volume account in Western Area, #3 nationally with a growth from $33,000 to over $300,000 in sales volume.

By January 2007, I developed 4 Surgical AFIB Centers of Excellence. These centers are surgical training sites to develop our surgeons skills in performing the MAZE procedure. They also contain our Key Opinion Leaders who were instrumental in developing the Atricure MAZE approach and our ablation platform.

Finished Q1 of 2007 at 100.38% to plan. 2007 quota increase of $500,000+

ETHICON ENDO-SURGERY, INC. December 2001 - June 2004

Breast Care Specialist, Oncology Division, Dallas, TX

Launched the Mammotome Breast Biopsy System and Neoprobe Gamma Detection System to General Surgeons and Interventional Radiologists in Houston, Dallas, Austin and central Texas. This was a new, disruptive technology introduced to the market. Responsibilities included integrating the Mammotome System into the surgeons and interventional radiologists practice of diagnosis and removal of malignant and non-malignant breast disease, and to establish the Neoprobe System as the OR standard for lymphatic mapping. Objectives included selling the capital platform and driving disposable usage.

Promoted to Field Sales Trainer, February 2003.

Reimbursement Training Responsibility to train sales reps in reimbursement coding/procedures, March 2003.

June 2003 transferred to Dallas, a strategically important territory, to re-establish the position of Mammotome and Neoprobe in several high profile accounts which had converted to the competition.

Converted 8 new Strategic Accounts in first 6 months in the Dallas Territory resulting in $300,000+ in new sales

2002, 100% quota attainment on Mammotome Disposables and Neoprobe.

2003, 100% quota attainment on Mammotome capital, Mammotome disposables and Neoprobe capital.

EDUCATION

B.S., Business Administration, University of Wisconsin,

La Crosse, WI

ADDITIONAL TRAINING

Kepner-Tregoe Wilson Learning Institute Miller-Heiman Challenger Sale and

Human Performance Training Leadership Effectiveness Training Strategic Selling Salesforce.com Trained

Strategy Implementation Sales Effectiveness Training

4 YEAR VARSITY LETTER WINNER, Football and Track, University of Wisconsin

President, Tau Kappa Epsilon Fraternity

Contact this candidate